How is (1S,5R)-1,5-Anhydro-1-(carboxymethyl)-3-C-(chloromethyl)-2-deoxy-5-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(isobutyryloxy)-2-pentenoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methyl-1,3-pentadien-1-yl}-D-erythro-pentitol (CAS: 1426953-24-3) typically synthesized?

This compound can be synthesized through a multi-step process involving the condensation of a carboxylic acid derivative with a pyran ring, followed by chloromethylation and anhydro cyclization. The synthesis typically requires the use of appropriate protecting groups and catalysts to achieve high selectivity and yield. Detailed procedures are available in the literature and are adapted for industrial-scale production.